Yunpan Li
Chinese Academy of Sciences(CN)Guangzhou Institutes of Biomedicine and Health(CN)
Publications by Year
Research Areas
Pluripotent Stem Cells Research, CRISPR and Genetic Engineering, Parkinson's Disease Mechanisms and Treatments, Epigenetics and DNA Methylation, Renal and related cancers
Most-Cited Works
- → Rolling back human pluripotent stem cells to an eight-cell embryo-like stage(2022)230 cited
- → Generation of a humanized mesonephros in pigs from induced pluripotent stem cells via embryo complementation(2023)53 cited
- → Live birth of chimeric monkey with high contribution from embryonic stem cells(2023)30 cited
- → VGLL1 cooperates with TEAD4 to control human trophectoderm lineage specification(2024)17 cited
- → β-Catenin safeguards the ground state of mousepluripotency by strengthening the robustness of the transcriptional apparatus(2020)16 cited
- → A single-cell chromatin accessibility dataset of human primed and naïve pluripotent stem cell-derived teratoma(2024)4 cited
- → Generation of an induced pluripotent stem cell line (GIBHi004-A) from a Parkinson’s disease patient with mutant DJ-1/PARK7 (p.L10P)(2020)3 cited
- → Generation of three induced pluripotent stem cell lines from a Parkinson's disease patient with mutant PARKIN (p. C253Y)(2020)1 cited
- → Generation of an induced pluripotent stem cell line (GIBHi003-A) from a Parkinson's disease patient with mutant PINK1 (p. I368N)(2019)1 cited
- Generation of 8-cell embryo-like cells and hypoblast-like cells from human pluripotent stem cells(2025)